MusclePharm Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 14.908 million compared to USD 16.993 million a year ago. Operating loss was USD 1.743 million compared to operating Income of USD 350,000 a year ago. Net loss was USD 2.251 million compared to USD 253,000 a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.01 a year ago. For the half year, sales was USD 28.029 million compared to USD 33.224 million a year ago. Operating loss was USD 1.470 million compared to operating Income of USD 901,000 a year ago. Net loss was USD 2.157 million compared to USD 313,000 a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.01 a year ago.